Table 3.

Overall incidence of evaluated clinical outcomes (n = 390)

Clinical outcome	% (95% CI)
100 days (acute)
Grade III-IV GVHD	21 (17-25)
100-day GI GVHD
Grade II-IV	14 (11-18)
Grade III-IV	8 (5-11)
1-year chronic GVHD	53 (48-58)
Rate of relapse
100 d	2 (1-4)
6 mo	5 (3-8)
1 y	10 (7-13)
Overall survival
100 d	85 (82-89)
6 mo	77 (73-81)
1 y	67 (62-72)
Disease-free survival
100 d	84 (80-88)
6 mo	74 (70-78))
1 y	63 (58-68)

CI indicates confidence interval; GI, gastrointestinal; and GVHD, graft-versus-host disease.